Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Clin Mol Hepatol. 2014;20(4):384-391.   Published online 2014 Dec 24     DOI: https://doi.org/10.3350/cmh.2014.20.4.384
Citations to this article as recorded by Crossref logo
Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis
Junyuan Zhu, Yifu Xia, Xiao Liu, Chunqing Zhang
Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
Variations in Practice Among Cirrhotic Patients With Portal Vein Thrombosis and Esophageal Varices: A North American Survey Study
Brandon G. Mui, Lauren T. Grinspan, James F. Crismale
American Journal of Gastroenterology.2024;[Epub]     CrossRef
Portal Vein Thrombosis in Patients with Cirrhosis
Peter L. Wang, Vijay Ramalingam, Lauren M. Yang
Current Hepatology Reports.2024; 23(1): 64.     CrossRef
Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis
Jiayi Ma, Naga P. Chalasani, Linus Schwantes‐An, Einar Stefán Björnsson
Alimentary Pharmacology & Therapeutics.2023; 57(1): 52.     CrossRef
Efficacy of endovascular treatment for completely occlusive acute–subacute portal and mesenteric vein thrombosis with severe complications in patients without cirrhosis
Hidemasa Saito, Fumie Sugihara, Tatsuo Ueda, Hiromitsu Hayashi, Sayaka Shirai, Taiga Matsumoto, Ryutaro Fujitsuna, Shin-ichiro Kumita
Japanese Journal of Radiology.2023; 41(5): 541.     CrossRef
Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study
Xuan Zhong, Shan Li, Jiali Hu, Jinlai Lu, Wei Wang, Miao Hu, Qinjuan Sun, Shuo Zhang, Xiaoqing Yang, Changqing Yang, Lan Zhong
Thrombosis Journal.2023;[Epub]     CrossRef
Oral Anticoagulation in Patients with Chronic Liver Disease
Raluca S. Costache, Andreea S. Dragomirică, Bogdan E. Gheorghe, Vasile D. Balaban, Silviu M. Stanciu, Mariana Jinga, Daniel O. Costache
Medicina.2023; 59(2): 346.     CrossRef
Anticoagulation for the Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis of Comparative Studies
Calvin Yao, Matthew Zhao, Brittney Ibrahim, Sammy Saab
Journal of Clinical and Experimental Hepatology.2023; 13(3): 404.     CrossRef
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
Antonio Guerrero, Laura del Campo, Fabio Piscaglia, Bernhard Scheiner, Guohong Han, Francesco Violi, Carlos-Noronha Ferreira, Luis Téllez, Thomas Reiberger, Stefania Basili, Javier Zamora, Agustín Albillos, Dominique Valla, Francois Durand, Tomás Artaza,
Journal of Hepatology.2023; 79(1): 69.     CrossRef
Portal vein thrombosis in cirrhosis: A literature review
Swathi Prakash, Jared Bies, Mariam Hassan, Adriana Mares, S. Claudia Didia
Frontiers in Medicine.2023;[Epub]     CrossRef
Comparative Efficacy of Anticoagulant Medications in Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis—A Systematic Review and Network Meta-analysis
Sami Ghazaleh, Justin Chuang, Wasef Sayeh, Amna Iqbal, Azizullah Beran, Yasmin Khader, Cameron Burmeister, Muhammad Aziz, Ragheb Assaly, Ali Nawras
American Journal of Therapeutics.2023; 30(6): e591.     CrossRef
Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta‐analysis
Suprabhat Giri, Ankita Singh, Kailash Kolhe, Aditya Kale, Akash Shukla
Journal of Gastroenterology and Hepatology.2023; 38(10): 1710.     CrossRef
Epidemiology, Diagnosis, and Treatment of Portal Vein Thrombosis
Jun-young Seo, Se Hwa Kim, Yang Jae Yoo, Ah Young Lee, Sang Jong Park
The Korean Journal of Medicine.2023; 98(4): 162.     CrossRef
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis
Lucia Giuli, Maria Pallozzi, Giulia Venturini, Antonio Gasbarrini, Francesca Romana Ponziani, Francesco Santopaolo
International Journal of Molecular Sciences.2023; 24(16): 12754.     CrossRef
Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis
Tong Hu, Yi-Han Li, Wen-Qiang Han, Kellina Maduray, Tong-Shuai Chen, Li Hao, Jing-Quan Zhong
American Journal of Cardiovascular Drugs.2023; 23(6): 683.     CrossRef
Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis
Shinya Yokoyama, Yoji Ishizu, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Tomoyuki Tsuzuki, Masatoshi Ishigami
Hepatology Research.2022; 52(2): 199.     CrossRef
Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management
Rabia Islam, Sumana Kundu, Surajkumar B Jha, Ana P Rivera, Gabriela Vanessa Flores Monar, Hamza Islam, Sri Madhurima Puttagunta, Ibrahim Sange
Cureus.2022;[Epub]     CrossRef
Haemostatic alterations and management of haemostasis in patients with cirrhosis
Ton Lisman, Stephen H. Caldwell, Nicolas M. Intagliata
Journal of Hepatology.2022; 76(6): 1291.     CrossRef
The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis
Zhiqi Zhang, Ying Zhao, Baofeng Han, Zhijun Zhu, Liying Sun, Xiangli Cui
Clinical and Applied Thrombosis/Hemostasis.2022; 28: 107602962211047.     CrossRef
Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo, José Ignacio Fortea
Journal of Clinical Medicine.2022; 11(21): 6435.     CrossRef
Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
Le Wang, Xiaozhong Guo, Xiangbo Xu, Valerio De Stefano, Aurelie Plessier, Carlos Noronha Ferreira, Xingshun Qi
Advances in Therapy.2021; 38(1): 495.     CrossRef
Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation
Cynthia Williams, Erin Stewart, Kendra D. Conzen, Scott Wolf, Timothy T. Tran
Seminars in Cardiothoracic and Vascular Anesthesia.2021; 25(3): 200.     CrossRef
Trombosis venosa portal extrahepática, manejo quirúrgico con derivación meso-Rex. Serie de 3 casos
Cesar Eduardo Jiménez Jiménez, Leonardo Randial Tagliapetra , Iván Enrique Silva Restrepo, Manuel Augusto Hossman-Galindo, Mario Bravo, Osiris Moreno Beltrán
Revista Colombiana de Cirugía .2021; 36(1): 98.     CrossRef
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases
Patrick G. Northup, Juan Carlos Garcia‐Pagan, Guadalupe Garcia‐Tsao, Nicolas M. Intagliata, Riccardo A. Superina, Lara N. Roberts, Ton Lisman, Dominique C. Valla
Hepatology.2021; 73(1): 366.     CrossRef
Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis
Emanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, Omri Cohen, Ettore Porreca, Marco Senzolo, Andrea De Gottardi, Marta Magaz, Juan-Carlos Garcia-Pagan, Walter Ageno
Thrombosis and Haemostasis.2021; 121(07): 867.     CrossRef
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study
Yong Lv, Wei Bai, Kai Li, Zhengyu Wang, Wengang Guo, Bohan Luo, Jianhong Wang, Qiuhe Wang, Enxin Wang, Dongdong Xia, Xiaomei Li, Jie Yuan, Na Han, Jing Niu, Zhanxin Yin, Daiming Fan, Guohong Han
American Journal of Gastroenterology.2021; 116(7): 1447.     CrossRef
Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis
Huan Chen, Jiaming Lei, Sicheng Liang, Gang Luo, Mingming Deng, Muhan Lü, Quirino Lai
Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1.     CrossRef
Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis
Yanying Gao, Hua Liu, Fei Tang, Xu Zhang, Fenghui Li, Qing Ye, Haixia Yuan, Hongmin Lv, Tao Han
Clinics and Research in Hepatology and Gastroenterology.2021; 45(2): 101649.     CrossRef
Management of Portal Vein Thrombosis in Cirrhosis
Matthew J. Stotts, Brian J. Wentworth, Patrick G. Northup
Seminars in Liver Disease.2021; 41(01): 079.     CrossRef
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis
Cheng Han Ng, Darren Jun Hao Tan, Kameswara Rishi Yeshayahu Nistala, Nicholas Syn, Jieling Xiao, Eunice Xiang Xuan Tan, Felicia Zuying Woo, Nicholas W. S. Chew, Daniel Q. Huang, Yock Young Dan, Arun J. Sanyal, Mark D. Muthiah
Hepatology International.2021; 15(5): 1196.     CrossRef
Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
Shixue Xu, Xiaozhong Guo, Benqiang Yang, Fernando Gomes Romeiro, Massimo Primignani, Nahum Méndez-Sánchez, Eric M. Yoshida, Andrea Mancuso, Frank Tacke, Carlos Noronha Ferreira, Valerio De Stefano, Xingshun Qi
Clinical and Translational Gastroenterology.2021; 12(10): e00409.     CrossRef
Current knowledge and management of portal vein thrombosis in cirrhosis
Marco Senzolo, Guadalupe Garcia-Tsao, Juan Carlos García-Pagán
Journal of Hepatology.2021; 75(2): 442.     CrossRef
A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
Shujie Dong, Huihong Qi, Yan Li, Peng Men, Maiwujudan Alifu, Yatong Zhang, Yongjun Li, Rongsheng Zhao
Hepatology International.2021; 15(6): 1356.     CrossRef
Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors
Marta Lopez‐Gomez, Elba Llop, Angela Puente, Marta Hernández Conde, Patricia Ruiz, Silvia Alvárez, Jose Luis Martínez, Javier Abad, Natalia Fernández, Christie Perelló, Carlos Fernández‐Carrillo, Carlos Ferre, Maria Trapero, Enrique Fraga, Javier Crespo,
Hepatology Research.2021; 51(10): 1064.     CrossRef
AGA Technical Review on Coagulation in Cirrhosis
Nicolas M. Intagliata, Perica Davitkov, Alina M. Allen, Yngve T. Falck-Ytter, Jonathan G. Stine
Gastroenterology.2021; 161(5): 1630.     CrossRef
The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis
Hoon Gil Jo, Youe Ree Kim, Eun Young Cho
The Korean Journal of Gastroenterology.2021; 78(3): 177.     CrossRef
Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures
Xiangbo Xu, Xiaozhong Guo, Ran Wang, Le Wang, Qianqian Li, Fangfang Yi, Hongyu Li, Xingshun Qi
Annals of Hepatology.2020; 19(5): 573.     CrossRef
Recent developments in the field of vascular liver diseases
Dominique C. Valla
Liver International.2020; 40(S1): 142.     CrossRef
Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis
Ming-hua Ai, Wei-guo Dong, Xiao-ping Tan, Ling Xu, Chao Xu, Qing Zhang, Yan Zhang, Jie Li
European Journal of Gastroenterology & Hepatology.2020; 32(10): 1395.     CrossRef
Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial
Ting Zhou, Xin Sun, Tao Zhou, Yueyue Li, Xiaoning Chen, Baoquan Cheng, Yanjing Gao
Clinical and Translational Gastroenterology.2020; 11(9): e00228.     CrossRef
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis
Oana Nicoară-Farcău, Guillem Soy, Marta Magaz, Anna Baiges, Fanny Turon, Angeles Garcia-Criado, Marta Barrufet, Marta Burrel, Virginia Hernández-Gea, Juan Carlos García-Pagán
Seminars in Thrombosis and Hemostasis.2020; 46(06): 673.     CrossRef
Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Rui Zhang, Xiaoquan Huang, Yingyi Jiang, Jian Wang, Shiyao Chen, Alessandro Granito
Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1.     CrossRef
Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis
Chiara Mazzarelli, Marcello Vangeli, Aldo Airoldi
Clinical Gastroenterology and Hepatology.2019; 17(4): 797.     CrossRef
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis
Kryssia I. Rodriguez-Castro, Alessandro Vitale, Mariangela Fadin, Sarah Shalaby, Patrizia Zerbinati, Maria Teresa Sartori, Stefano Landi, Irene Pettinari, Fabio Piscaglia, Guohong Han, Patrizia Burra, Paolo Simioni, Marco Senzolo
European Journal of Gastroenterology & Hepatology.2019; 31(1): 34.     CrossRef
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis
Nicolas M. Intagliata, Stephen H. Caldwell, Armando Tripodi
Gastroenterology.2019; 156(6): 1582.     CrossRef
Anticoagulation in the cirrhotic patient
Laura Turco, Emmanuelle de Raucourt, Dominique-Charles Valla, Erica Villa
JHEP Reports.2019; 1(3): 227.     CrossRef
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis
Jessica P. E. Davis, Amy G. Ogurick, Carrie E. Rothermel, Min-Woong Sohn, Nicolas M. Intagliata, Patrick G. Northup
Clinical and Applied Thrombosis/Hemostasis.2019; 25: 107602961988802.     CrossRef
Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience
Kerstin Rosenqvist, Charlotte Ebeling Barbier, Fredrik Rorsman, Per Sangfelt, Rickard Nyman
Acta Radiologica.2018; 59(8): 953.     CrossRef
Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy
Junyang Luo, Mingan Li, Youyong Zhang, Haofan Wang, Mingsheng Huang, Zhengran Li, Junwei Chen, Chun Wu, Jiesheng Qian, Shouhai Guan, Zaibo Jiang
European Radiology.2018; 28(9): 3661.     CrossRef
Timing of anticoagulation for portal vein thrombosis in liver cirrhosis: An Italian internist’s perspective
Nicoletta Riva, Walter Ageno
Journal of Translational Internal Medicine.2018; 6(1): 6.     CrossRef
Transient portal vein thrombosis in liver cirrhosis
Xingshun Qi, Xiaozhong Guo, Eric M. Yoshida, Nahum Méndez-Sánchez, Valerio De Stefano, Frank Tacke, Andrea Mancuso, Yasuhiko Sugawara, Sien-Sing Yang, Rolf Teschke, Ankur Arora, Dominique-Charles Valla
BMC Medicine.2018;[Epub]     CrossRef
Oral Anticoagulation in Patients With Liver Disease
Arman Qamar, Muthiah Vaduganathan, Norton J. Greenberger, Robert P. Giugliano
Journal of the American College of Cardiology.2018; 71(19): 2162.     CrossRef
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis
Tomas Artaza, Miriam Lopes, Marta Romero, Ana-Zaida Gómez, Gema de la Cruz, Juan José Sánchez, Concepción González, Rafael Gómez
Gastroenterología y Hepatología.2018; 41(10): 611.     CrossRef
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
Marco Senzolo, Nicoletta Riva, Francesco Dentali, Kryssia Rodriguez-Castro, Maria Teresa Sartori, Soo-Mee Bang, Ida Martinelli, Sam Schulman, Adriano Alatri, Jan Beyer-Westendorf, Matteo Nicola Dario Di Minno, Walter Ageno
Clinical and Translational Gastroenterology.2018; 9(8): e176.     CrossRef
Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Stefania Basili, Daniele Pastori, Valeria Raparelli, Francesco Violi
Therapeutic Advances in Gastroenterology.2018; 11: 175628481879356.     CrossRef
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis
Tomas Artaza, Miriam Lopes, Marta Romero, Ana-Zaida Gómez, Gema de la Cruz, Juan José Sánchez, Concepción González, Rafael Gómez
Gastroenterología y Hepatología (English Edition).2018; 41(10): 611.     CrossRef
Anticoagulation in chronic liver disease
Ameet Dhar, Benjamin H. Mullish, Mark R. Thursz
Journal of Hepatology.2017; 66(6): 1313.     CrossRef
Warfarin
Reactions Weekly.2017; 1649(1): 249.     CrossRef
Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation
Andrea Mancuso
Current Hepatology Reports.2017; 16(2): 158.     CrossRef
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis
Lorenzo Loffredo, Daniele Pastori, Alessio Farcomeni, Francesco Violi
Gastroenterology.2017; 153(2): 480.     CrossRef
Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis
Hui Chen, Lei Liu, Xingshun Qi, Chuangye He, Feifei Wu, Daiming Fan, Guohong Han
European Journal of Gastroenterology & Hepatology.2016; 28(1): 82.     CrossRef
Nontumoral portal vein thrombosis in patients awaiting liver transplantation
Hui Chen, Fanny Turon, Virginia Hernández‐Gea, Josep Fuster, Angeles Garcia‐Criado, Marta Barrufet, Anna Darnell, Constantino Fondevila, Juan Carlos Garcia‐Valdecasas, Juan Carlos Garcia‐Pagán
Liver Transplantation.2016; 22(3): 352.     CrossRef
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?
Aaron Liew, James Douketis
Internal and Emergency Medicine.2016; 11(8): 1037.     CrossRef
Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment
Alessandra Dell’Era, Susana Seijo
Expert Opinion on Orphan Drugs.2016; 4(9): 927.     CrossRef
Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver
Kerstin Rosenqvist, Lars-Gunnar Eriksson, Fredrik Rorsman, Per Sangfelt, Rickard Nyman
Acta Radiologica.2016; 57(5): 572.     CrossRef
Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis
Jian-Ying Zhang, Yun-Bing Wang, Jian-Ping Gong, Fan Zhang, Yong Zhao
The American Surgeon.2016; 82(12): 1169.     CrossRef
Reduced Survival in Bariatric Surgery Candidates Delayed or Denied by Lack of Insurance Approval
Eleisha Flanagan, Iman Ghaderi, D. Wayne Overby, Timothy M. Farrell
The American Surgeon.2016; 82(2): 166.     CrossRef
Optimal Management of Portal Vein Thrombosis in Patients with Liver Cirrhosis: a Review
Geneviève Huard, Julien Bissonnette, Marc Bilodeau
Current Hepatology Reports.2015; 14(3): 203.     CrossRef